Relmada Therapeutics Inc (NAS:RLMD)
$ 4.54 -0.41 (-8.28%) Market Cap: 484.28 Mil Enterprise Value: 266.55 Mil PE Ratio: 0 PB Ratio: 2.17 GF Score: 29/100

Relmada Therapeutics Inc (RLMD) Transcripts

  • 1